| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $2.47 (Beat by $0.32) |
| EPS GAAP Actual | $2.47 (Beat by $0.32) |
| Revenue Actual | $34.979B |
| Revenue Surprise | Beat by $34979M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 15.75 | 10 | 13.31903 | 17.46405 | 1 |
| Dec 2029 | 16.4 | 9.6 | 14.00088 | 20.17469 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.32 | 0.32 | 34.979B | -3.38% | 34979M |
| FQ2 2025 (Jun 2025) | 2.15 | 2.15 | 33.323B | -16.77% | 33323M |
| FQ1 2025 (Mar 2025) | 1.19 | 1.19 | 31.726B | -12.88% | 31726M |
| FQ4 2024 (Dec 2024) | -0.0048 | -0.0048 | 33.685B | -13.61% | 33685M |
| FQ3 2024 (Sep 2024) | 0.83 | 0.83 | 36.163B | -9.62% | 36163M |
| FQ2 2024 (Jun 2024) | 2.4 | 2.4 | 38.911B | 9.82% | 38911M |
| FQ1 2024 (Mar 2024) | 1.74 | 1.74 | 35.811B | 3.95% | 35811M |
| FQ4 2023 (Dec 2023) | 2.88 | 2.88 | 38.27B | -20.18% | 38270M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 2.8386 | -- | 2.49887 | 3.38557 | 6 |
| FQ3 2028 (Sep 2028) | 3.6599 | -- | 3.22188 | 4.36513 | 6 |
| FQ2 2028 (Jun 2028) | 4.0181 | -- | 3.53721 | 4.79235 | 6 |
| FQ1 2028 (Mar 2028) | 2.8688 | -- | 2.52546 | 3.42159 | 6 |
| FQ4 2027 (Oct 2027) | 4.9805 | -- | 3.88581 | 5.92301 | 4 |
| FQ3 2027 (Jul 2027) | 4.9131 | -- | 3.83323 | 5.84286 | 4 |
| FQ2 2027 (Jun 2027) | 3.74336 | -- | 3.29535 | 4.46467 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 31.71B | -- | 28.79B | 36.41B | 3 |
| FQ3 2028 (Sep 2028) | 31.41B | -- | 28.52B | 36.06B | 3 |
| FQ2 2028 (Jun 2028) | 32.38B | -- | 29.4B | 37.18B | 3 |
| FQ1 2028 (Mar 2028) | 29.82B | -- | 27.08B | 34.24B | 3 |
| FQ4 2027 (Oct 2027) | 64.3B | -- | 53.43B | 73.66B | 2 |
| FQ3 2027 (Jul 2027) | 61.66B | -- | 51.24B | 70.64B | 2 |
| FQ2 2027 (Jun 2027) | 33.95B | -- | 30.83B | 38.98B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.32 | 0.32 | 100% | |
| FQ2 2025 (Jun 2025) | 2.15 | 2.15 | 100% | |
| FQ1 2025 (Mar 2025) | 1.19 | 1.19 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0048 | -0.0048 | 100% | |
| FQ3 2024 (Sep 2024) | 0.83 | 0.83 | 100% | |
| FQ2 2024 (Jun 2024) | 2.4 | 2.4 | 100% | |
| FQ1 2024 (Mar 2024) | 1.74 | 1.74 | 100% | |
| FQ4 2023 (Dec 2023) | 2.88 | 2.88 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $34.98B | $34979M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $33.32B | $33323M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $31.73B | $31726M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $33.69B | $33685M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $36.16B | $36163M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $38.91B | $38911M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $35.81B | $35811M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $38.27B | $38270M | 100% |